Küresel Kamusal Mal Olarak Covid-19 Aşısı

Arkan YUSUFOĞLU, (Ankara Hacı Bayram Veli Üniversitesi, İİBF, Maliye, Ankara, Türkiye)
Muharrem ÇAKIR (Ankara Hacı Bayram Veli Üniversitesi, İİBF, Maliye, Ankara, Türkiye)
Vergi Sorunları Dergisi
0 0
Yıl: 2022 Cilt: 45 Sayı: 403 Sayfa Aralığı: 86 - 105 Metin Dili: Türkçe İndeks Tarihi: 16-06-2022

Küresel Kamusal Mal Olarak Covid-19 Aşısı

Öz:
Covid 19 aşılarının geliştirilmesiyle birlikte söz konusu aşıların küresel kamusal mal olarak kabul edilmelerine yönelik çağrılar ortaya çıkmıştır. Bu çalışmada Covid 19’a karşı geliştirilen aşıların hangi şartlarda küresel kamusal mal olarak değerlendirilebileceği, bunların sunumunda geçerli olacak yöntemler ve gerekli kolektif eylem biçimleri analiz edilmektedir. Bu bağlamda aşı geliştirme çalışmaları sonucunda üretilen bilginin –fikri mülkiyet hakları kapsamında koruma altına alınmamak kaydıyla- ve bağışıklık kazandırma anlamında aşılama faaliyetinin küresel kamusal mal konsepti içinde değerlendirilebileceği sonucuna varılmıştır. Küresel kamusal mallar teorisi açısından bilgi üretiminde en iyi vuruş, aşılama çalışmaları açısından ise en zayıf halka yöntemi geçerli olacaktır.
Anahtar Kelime:

COVID-19 VACCINE AS A PUBLIC GLOBAL GOOD

Öz:
With the development of Covid 19 vaccines, calls have emerged for their acceptance as a global public good. In this study in which conditions that covid 19 vaccines can be considered as global public goods, which aggregation technology prevails and necessary collective action types are analyzed. In this context, it was concluded that the knowledge produced as a result of the vaccine research and development processes –provided that it is not protected under intellectual property rights- and the vaccination activity as immunization can be evaluated within the concept of global public goods. In terms of global public goods theory, knowledge production will be a best shot and vaccination will be a weakest link global public good.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • Anand, Prathivadi Bhayankaram, “Financing the Provision of Global Public Goods”, The World Economy, Volume 27, Issue 2, 2004.
  • Arhin-Tenkorang, Dyna ve Conceição, Pedro, “Beyond Communicable Disease Control: Health in the Age of Globalization”, (Ed. Kaul vd.), Providing Global Public Goods: Managing Globalization, Oxford University Press, New York, 2003.
  • Ayrangöl, Zülküf, Küresel Kamusal Mallar ve Su Hakkı, Atatürk Üniversitesi Sosyal Bilimler Enstitüsü, Yayımlanmamış Doktora Tezi, 2012.
  • Barış, Abdullah ve Barlas, Emin, “Kamu Maliyesi Teorisinde Küresel Kamusal Mallar”, Gaziosmanpaşa Üniversitesi Sosyal Bilimler Araştırmaları Dergisi, 12/1, 2017.
  • Barrett, Scott, “Creating Incentives for Cooperation: Strategic Choices”, (Ed. Kaul vd.), Providing Global Public Goods: Managing Globalization, Oxford University Press, New York, 2003.
  • Barrett, Scott, WHY COOPERATE? The Incentive to Supply Global Public Goods, Oxford University Press, 2007.
  • Birdsall, Nancy ve Diofasi, Anna, Global Public Goods for Development: How Much and What For, Center For Global Development, 2015. Bodansky, Daniel, “What’s in a Concept? Global Public Goods, International Law, and Legitimacy”, The European Journal of International Law, Cilt. 23 No. 3, 2012.
  • Bollyky, Thomas J. ve Bown, Chad P., “The Tragedy Of Vaccine Nationalism: Only Cooperation Can End The Pandemic”, Foreign Affairs, 99(5), 2020.
  • Chakrabarti, Milindo, COVID-19: Make Health Systems a Global Public Good, 2020, https:// oecd-development-matters.org/2020/04/29/ covid-19-make-health-systems-a-globalpublic- good/, (Erişim: 02.04.2021).
  • Correai Carlos, “Managing the Provision of Knowledge: The Design of Intellectual Property Laws”, (Ed. Kaul vd.), Providing Global Public Goods: Managing Globalization, Oxford University Press, New York, 2003.
  • Dedebek, Emin, “Küresel Kamusal Malların Finansmanı”, Balkan Sosyal Bilimler Dergisi, Cilt. 6, Sayı. 11, 2017.
  • Deneulin, Severine ve Townsend, Nicholas, Public Goods, Global Public Goods and The Common Good, ESRC Research Group on Wellbeing in Developing Countries, Working Paper
  • Ener, M. ve Demircan, E. “Küreselleşme Sürecinde Değişen Devlet Anlayışından Kamu Hizmetlerinin Dönüşümüne: Sağlık Hizmetlerinde Piyasa Mekanizmaları”, Süleyman Demirel Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi, Cilt 13, Sayı 1, 2008.
  • European Commission, ANNEX to the Commission Decision on approving the agreement with Member States on procuring Covid-19 vaccines on behalf of the Member States and related procedures, Brussels, 18.6.2020 C(2020) 4192 final ANNEX, 2020.
  • Garrison, Christopher, Background Paper on WHO Workshop on Intellectual Property Rights and Vaccines in Developing Countries, World Health Organization, Geneva, 19–20 April 2004.
  • Gaviria, Mario ve Kilic, Burcu, “A Network Analysis of COVID-19 mRNA Vaccine Patents”, Nature Biotechnology, Cilt: 39, 2021.
  • Global Health Centre, “COVID-19 Vaccines R&D Investments”. Graduate Institute of International and Development Studies. 2021. knowledgeportalia. org/covid19-r-d-funding, (Erişim: 05.07.2021).
  • https://covid19.trackvaccines.org/vaccines/, (Erişim: 21.02.2022). https://covid19.who.int/, (Erişim: 21.02.2022).
  • h t t p s : / / n e w s . u n . o r g / e n / story/2021/04/1089392, (Erişim: 07.07.2021). https://ourworldindata.org/covid-vaccinations, (Erişim: 21.02.2022).
  • https://www.gavi.org/covax-vaccine-rollout, (Erişim: 21.02.2022).
  • https://www.gavi.org/sites/default/files/ covid/covax/COVAX-AMC-Donors-Table.pdf, (Erişim: 21.02.2022).
  • https://www.gavi.org/sites/default/files/ covid/covax/COVAX-Dose-Donation-Table, (Erişim: 21.0022022).
  • https://www.gavi.org/sites/default/files/ covid/covax/COVAX-Supply-Forecast.pdf, (Erişim: 21.02.2022).
  • https://www.un.org/press/en/2021/ sc14438.doc.htm, (Erişim: 03.04.2021). https://www.who.int/initiatives/actaccelerator/ covax, (Erişim: 25.07.2021).
  • IMF-World Bank, Poverty Reduction And Global Public Goods: Issues For The World Bank In Supporting Global Collective Action, Development Committee, DC/2000.
  • Inge Kaul, I ve Michael Faust, “Global Public Goods And Health: Taking The Agenda Forward”, Bulletin of the World Health Organization, Sayı: 79, 2001.
  • Jayaraman, Rajshri ve Kanbur, Ravi, “International Public Goods And The Case For Foreign Aid”, (Ed. Kaul vd.), Global Public Goods: International Cooperation in the 21st Century, Oxford University Press, 1999.
  • Kaul, Igne, Grunberg, Isabella ve Stern, Marc, “Defining Global Public Goods”, (Ed. Kaul vd.), Global Public Goods: International Cooperation in the 21st Century, Oxford University Press, 1999.
  • Kaul, Inge, Conceiço, Pedro, Le Goulven, Katell ve Mendoza, Ronald U, “Why Do Global Public Goods Matter Today”, (Ed. Kaul vd.), Providing Global Public Goods: Managing Globalization, Oxford University Press, New York, 2003.
  • Long, David ve Wooley, Frances, Global Public Goods: Critique of a UN Discourse, Global Governance 15, 2009.
  • Michael Kremer, “Creating Markets for New Vaccines. Part I: Rationale”, (Ed. Jaffe vd.), Innovation Policy and the Economy Volume 1, MIT Press, Cambridge, 2000.
  • Moon, Suerie, Røttingen, John-Arne ve Frenk, Julio, “Global Public Goods For Health: Weaknesses and Opportunities in The Global Health System”, Health Economics, Policy and Law, Sayı. 12, 2007.
  • Morrissey. Oliver, Velde, Dirk Willem te ve Hewitt, Adrian, “Defining International Public Goods Conceptual Issues”, (Ed. Ferroni, M.; Moody, A.), International Public Goods: Incentives, Measurement, and Financing, Washington, DC: World Bank and Kluwer, 2002.
  • Mutlu, Ayşegül, “Küresel Kamusal Mallar Bağlamında Sağlık Hizmetleri ve Çevre Kirlenmesi: Üretim, Finansman ve Yönetim Sorunları”, Maliye Dergisi, Sayı 150, 2006.
  • Oral, Burcu Gediz, “Sağlık Hizmetlerinin Küresel Kamusal Mal Olarak Değerlendirilmesi: Uluslararası Örgütler”, Finans Politik & Ekonomik Yorumlar, Cilt 51, Sayı 588, 2014.
  • Sandler, Todd ve Arce, Daniel G., “A Conceptual Framework for Understanding Global and Transnational Public Goods for Health”, Fiscal Studies, Cilt. 12, Sayı. 4, 2002.
  • Sandler, Todd, “Assessing the Optimal Provision of Public Goods: In Search of the Holy Grail”, (Ed. Kaul vd.), Providing Global Public Goods: Managing Globalization,Oxford University Press, New York, 2003.
  • Sandler, Todd, “COVID-19 and Collective Action”, Peace Economics, Peace Science and Public Policy, Cilt. 26, Sayı. 3, 2020.
  • Sandler, Todd, “Global and Regional Public Goods: A Prognosis for Collective Action”, Fiscal Studies, Cilt. 19, Sayı. 3, 1998.
  • Sandler, Todd, “Intergenerational Public Goods: Strategies , Efficiency and Institutions”, (Ed. Kaul vd.), Global Public Goods: International Cooperation in the 21st Century, Oxford University Press, 1999.
  • Sandler, Todd, On Financing Global and International Public Goods, Policy Research Working Paper 2638, The World Bank Ekonomic Policy and Prospects Group, 2001.
  • Sankar, Ulaganathan, Global Public Goods, Madras School of Economics, Working Paper 28/2008.
  • Santos Rutschman, Ana, “The Reemergence of Vaccine Nationalism”, Georgetown Journal of International Affairs Online, 2020, 1.
  • https://europepmc.org/api/fulltextRepo?pprId =PPR297426&type=FILE&fileName=EMS11995 6pdf.pdf&mimeType=application/pdf, (Erişim: 14.07.2021).
  • Savaşan, Fatih, Kamu Ekonomisi, Dora Basım Yayın Dağıtım, 2016.
  • Smith, Richard, Woodward, David, Acharya, Arnab, Beaglehole, Robert ve Drager, Nick, “Communicable disease control: a Global Public Good perspective”, Health Policy and Planning, Cilt. 19, Sayı. 5, 2004.
  • Stiglitz, Joseph E., “Knowledge as a Global Public Good”, (Ed. Kaul vd.), Global Public Goods: International Cooperation in the 21st Century, Oxford University Press, 1999.
  • Towse, Adrian, “How Should the World Pay for a COVID-19 Vaccine ?”, Monographs, Office of Health Economics, Number 002287. S.3-6, 2020.
  • UNESCO, Joint Statement by the UNESCO International Bioethics Committee (IBC) and the UNESCO World Commission on the Ethics of Scientific Knowledge and Technology (COMEST), SHS/BIO/IBC-COMEST/COVID-19 Vaccines Paris, 24 February 2021. https://www.un.org/ press/en/2021/sgsm20620.doc.htm, (Erişim: 03.04.2021).
  • UNIDO, “Public Goods For Economic Development, Vienna: UNIDO”, 2008, https://www. unido.org/sites/default/files/200902/Public% 20goods%20for%20economic%20development_ sale_0.pdf, (Erişim: 05.07.2021).
  • United Nations, “Recovering from COVID- 19: the importance of investing in global public goods for health”, Department of Economic and Social AffairsSocial Inclusion, 2020, https://www.un.org/development/desa/ dspd/2020/07/recovering-from-covid19/, (Erişim: 02.04.2021).
  • WHO, “Global Public Goods for Health”, The Report of Working Group 2 of the Commission Macroeconomics and Health, Geneva, 2002. WHO, Access to COVID-19 Tools (Act) Accelerator, 2020a.
  • WHO, Seventy-Third World Health Assembly, “COVID-19 response”, WHA 73.1, 19 May 2020b. https://apps.who.int/gb/ebwha/ pdf_files/WHA73/A73_R1-en.pdf, (Erişim: 03.04.2021).
  • World Trade Organization, (2020), “WTO, Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19, Communication from India and South Africa”, IP/C/W/669, 2 October 2020, https://docs.wto.org/dol2fe/ Pages/SS/directdoc.aspx?filename=q:/IP/C/
  • World Trade Organization, (2021),” Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19 Revised Decision Text Communication From The African Group, The Plurinational State Of Bolivia, Egypt, Eswatini, Fıji, India, Indonesia…” IP/C/W/669/Rev.1, 25 May 2021, https://docs.wto.org/dol2fe/Pages/ SS/directdoc.aspx?filename=q:/IP/C/W669R1. pdf&Open=True, (Erişim: 14.06.2021).
  • Yalçın, Arman Zafer, “Küresel Çevre Politikalarının Küresel Kamusal Mallar Perspektifinden Değerlendirilmesi”, Balıkesir Üniversitesi Sosyal Bilimler Enstitüsü Dergisi, Cilt 12, Sayı 21, 2009.
  • Yamey, Gavin, Schäferhoff, Marco, Pate, Muhammad, Chawla, Mukesh, Ranson, Kent, Zhao, Feng, Hatchett, Richard ve Wilder, Richard, Funding the development and manufacturing of COVID-19 vaccines: Background paper for the World Bank/CEPI financing COVID-19 vaccine development consultation on February 20, 2020.
  • Yılmaz, Binhan Elif ve Yaraşır, Sevinç, “Bir Küresel Kamusal Mal Olarak Sağlık ve Finansmanında Resmi Kalkınma Yardımlarının Rolü”, İstanbul Üniversitesi İktisat Fakültesi Maliye Araştırma Merkezi Konferansları, Cilt. 0, Sayı 55, 2011.
  • Zacher, Mark W., “Global Epidemiological Surveillance: International Cooperation To Monitor Infectious Diseases”, (Ed. Kaul vd.), Global Public Goods: International Cooperation in the 21st Century, Oxford University Press, 1999.
APA YUSUFOGLU A, ÇAKIR M (2022). Küresel Kamusal Mal Olarak Covid-19 Aşısı. , 86 - 105.
Chicago YUSUFOGLU ARKAN,ÇAKIR MUHARREM Küresel Kamusal Mal Olarak Covid-19 Aşısı. (2022): 86 - 105.
MLA YUSUFOGLU ARKAN,ÇAKIR MUHARREM Küresel Kamusal Mal Olarak Covid-19 Aşısı. , 2022, ss.86 - 105.
AMA YUSUFOGLU A,ÇAKIR M Küresel Kamusal Mal Olarak Covid-19 Aşısı. . 2022; 86 - 105.
Vancouver YUSUFOGLU A,ÇAKIR M Küresel Kamusal Mal Olarak Covid-19 Aşısı. . 2022; 86 - 105.
IEEE YUSUFOGLU A,ÇAKIR M "Küresel Kamusal Mal Olarak Covid-19 Aşısı." , ss.86 - 105, 2022.
ISNAD YUSUFOGLU, ARKAN - ÇAKIR, MUHARREM. "Küresel Kamusal Mal Olarak Covid-19 Aşısı". (2022), 86-105.
APA YUSUFOGLU A, ÇAKIR M (2022). Küresel Kamusal Mal Olarak Covid-19 Aşısı. Vergi Sorunları Dergisi, 45(403), 86 - 105.
Chicago YUSUFOGLU ARKAN,ÇAKIR MUHARREM Küresel Kamusal Mal Olarak Covid-19 Aşısı. Vergi Sorunları Dergisi 45, no.403 (2022): 86 - 105.
MLA YUSUFOGLU ARKAN,ÇAKIR MUHARREM Küresel Kamusal Mal Olarak Covid-19 Aşısı. Vergi Sorunları Dergisi, vol.45, no.403, 2022, ss.86 - 105.
AMA YUSUFOGLU A,ÇAKIR M Küresel Kamusal Mal Olarak Covid-19 Aşısı. Vergi Sorunları Dergisi. 2022; 45(403): 86 - 105.
Vancouver YUSUFOGLU A,ÇAKIR M Küresel Kamusal Mal Olarak Covid-19 Aşısı. Vergi Sorunları Dergisi. 2022; 45(403): 86 - 105.
IEEE YUSUFOGLU A,ÇAKIR M "Küresel Kamusal Mal Olarak Covid-19 Aşısı." Vergi Sorunları Dergisi, 45, ss.86 - 105, 2022.
ISNAD YUSUFOGLU, ARKAN - ÇAKIR, MUHARREM. "Küresel Kamusal Mal Olarak Covid-19 Aşısı". Vergi Sorunları Dergisi 45/403 (2022), 86-105.
Sayfa Oluşturulma Tarihi
18-04-2024 0:58

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları